HI SB585 | 2016 | Regular Session

Status

Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on January 23 2015 - 25% progression, died in committee
Action: 2016-01-21 - Re-Referred to CPH, JDL.
Pending: Senate Commerce, Consumer Protection, and Health Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Beginning January 1, 2016, allows manufacturers of investigational drugs, biological products, or devices to make available such drugs, products, or devices to terminally ill patients under certain conditions.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Terminally Ill Patients; Investigational Drugs, Biological Products, or Devices; Access

Sponsors


History

DateChamberAction
2016-01-21SenateRe-Referred to CPH, JDL.
2015-12-17 Carried over to 2016 Regular Session.
2015-01-26SenateReferred to HTH/CPN, JDL.
2015-01-26SenatePassed First Reading.
2015-01-23SenateIntroduced.

Hawaii State Sources


Bill Comments

feedback